Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

PD-1 Inhibitor Combined with ADC, the Strong Cooperation of Innovent and Remegen

Far-away from the Crowd/PharmaSourcesJuly 25, 2023

Tag: ADC , Anti-tumor , clinical trial

PharmaSources Customer Service